Coloplast A/S (FRA:CBHD)

Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of EUR 14.56 billion. The enterprise value is 17.77 billion.

Market Cap	14.56B
Enterprise Value	17.77B

Important Dates

The last earnings date was Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	Dec 5, 2025

Share Statistics

Current Share Class	207.17M
Shares Outstanding	n/a
Shares Change (YoY)	+0.17%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	5.32%
Owned by Institutions (%)	19.86%
Float	143.39M

Valuation Ratios

The trailing PE ratio is 27.25 and the forward PE ratio is 18.72.

PE Ratio	27.25
Forward PE	18.72
PS Ratio	3.90
PB Ratio	7.88
P/TBV Ratio	n/a
P/FCF Ratio	19.87
P/OCF Ratio	15.82
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.96, with an EV/FCF ratio of 24.25.

EV / Earnings	33.26
EV / Sales	4.76
EV / EBITDA	14.96
EV / EBIT	17.33
EV / FCF	24.25

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 1.82.

Current Ratio	1.30
Quick Ratio	0.76
Debt / Equity	1.82
Debt / EBITDA	2.83
Debt / FCF	4.59
Interest Coverage	10.74

Financial Efficiency

Return on equity (ROE) is 27.26% and return on invested capital (ROIC) is 13.08%.

Return on Equity (ROE)	27.26%
Return on Assets (ROA)	9.85%
Return on Invested Capital (ROIC)	13.08%
Return on Capital Employed (ROCE)	18.74%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	219,897
Profits Per Employee	31,450
Employee Count	16,983
Asset Turnover	0.57
Inventory Turnover	2.38

Taxes

In the past 12 months, Coloplast has paid 293.23 million in taxes.

Income Tax	293.23M
Effective Tax Rate	35.44%

Stock Price Statistics

The stock price has decreased by -39.26% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-39.26%
50-Day Moving Average	71.96
200-Day Moving Average	78.75
Relative Strength Index (RSI)	37.64
Average Volume (20 Days)	437

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Coloplast had revenue of EUR 3.73 billion and earned 534.11 million in profits. Earnings per share was 2.37.

Revenue	3.73B
Gross Profit	2.53B
Operating Income	1.03B
Pretax Income	827.35M
Net Income	534.11M
EBITDA	1.15B
EBIT	1.03B
Earnings Per Share (EPS)	2.37

Balance Sheet

The company has 150.63 million in cash and 3.36 billion in debt, with a net cash position of -3.21 billion.

Cash & Cash Equivalents	150.63M
Total Debt	3.36B
Net Cash	-3.21B
Net Cash Per Share	n/a
Equity (Book Value)	1.85B
Book Value Per Share	8.21
Working Capital	317.33M

Cash Flow

In the last 12 months, operating cash flow was 920.00 million and capital expenditures -187.46 million, giving a free cash flow of 732.55 million.

Operating Cash Flow	920.00M
Capital Expenditures	-187.46M
Free Cash Flow	732.55M
FCF Per Share	n/a

Margins

Gross margin is 67.87%, with operating and profit margins of 27.46% and 14.30%.

Gross Margin	67.87%
Operating Margin	27.46%
Pretax Margin	22.15%
Profit Margin	14.30%
EBITDA Margin	30.78%
EBIT Margin	27.46%
FCF Margin	19.62%

Dividends & Yields

This stock pays an annual dividend of 3.08, which amounts to a dividend yield of 4.75%.

Dividend Per Share	3.08
Dividend Yield	4.75%
Dividend Growth (YoY)	4.37%
Years of Dividend Growth	17
Payout Ratio	129.96%
Buyback Yield	-0.17%
Shareholder Yield	4.58%
Earnings Yield	3.67%
FCF Yield	5.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 19, 2012. It was a forward split with a ratio of 5.

Last Split Date	Dec 19, 2012
Split Type	Forward
Split Ratio	5

Scores

Coloplast has an Altman Z-Score of 4.11 and a Piotroski F-Score of 7.

Altman Z-Score	4.11
Piotroski F-Score	7